News
GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
EXCLUSIVE: Top doctor Dr Kim Boyd says its programmes are needed 'more than ever' despite the boom in weight loss drugs.
This week's exercise is a perfect addition for someone on a GLP-1 prescription, because it addresses another element of ...
Most of the scariest side effects of weight-loss drugs like Ozempic, Wegovy, and Zepbound have been gastrointestinal.
EXPERTS have revealed there could be a ‘golden dose’ of Mounjaro that helps shift the most weight – and it’s not the highest ...
Ongoing research is needed to fully understand their risks, especially for long-term and higher-dose users. However, many ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
LynFit Nutrition is a recurring segment featured on“CT BUZZ,” where Metabolic Weight Loss & Fat Burning Expert, Lisa Lynn, ...
For people beginning their weight loss journey, a combination of physical activity and a healthy diet – such as the ...
The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results